INTRODUCTION
E~ELURANE (ET"RANE ~ has been shown to depress myocardial contractility in the isolated papillary muscle of cats. ,.z Also in cats enflurane has been shown to depress preganglionic sympathetic nervous acticity. 3 In patients fiee of cardlo-respiratory disease, enflurane has been shown to produce minimal cardiovascular depression? ~':' This study was carried out to evaluate the cardiovascular actions of enfluranepancuronium anaesthesia in patients with cardiac valvular disease.
MATERIAL AND METHOD
Six patients with valvular heart disease scheduled for mitral and/or aortic valve replacement were studied. Mean age of the patients was 56 years (range 48-63 years). Of the three women and three men that were subjects for the study, three suffered from aortic valve disease and underwent aortic valve replacement only, two patients suffered flom both aortic and mitral valve disease and underwent double valve replacement, and one patient needed mitral valve replacement only. The mean cardiac index measured prior to surgery during cardiac catherization was 2.5 I/min/m 2 (range 1.7-3.8 I/minim2). All patients were in functional groups It-Ill (three in each group) according to the N .Y.H.A. classification.
Premedication consisted of diazepam 0.1 mg/kg and scopolamine 0.005 mg/kg given intramuscularly two hours before induction of anaesthesia. Under local anaesthesia a radial artery was cannulated and a Swan-Ganz flow directed thermodilution catheter was inserted through the right internal jugular vein by a percutaneous technique. In addition, a central yen- The following parameters were recorded prior to induction of anaesthesia and after 15 minutes of enflurane-pancu,'onium anaesthesia before operation: mean arterial pressure (MAP), calculated as the diastolic pressure plus one-third of the pulse amplitude; central venous pressure (CVP), pulmonary arterial mean pressure (PAMP), pulmonary capillary wedge pressure (PCWP) (recorded using Statham P23 ribtransducers positioned in the midaxillary line of the patient placed supine on the operating table); heart rate (HR), counted from the pulse curve. The electrocardiogram was also recorded and together with the parameters mentioned above, was recorded on a Mingograph (Elema-Schoenander) 6-channel recorder. Cardiac output was measured by the thermodilution method 6 by a cardiac output computer, model 9500 Edwards. The mean of three measurements of cardiac outpu~ was used for calculations. Cardiac index (CI) was calculated using the height and weight nomogram ofduBois. 7 Pulmonary vascular resistance (PVR) was calculated from the formula ((PAMP -PCWP) • 80)/CO dynes/sec/cm-L Systemic vascular resistance (SVR) was calculated from the formula ((MAP -CVP) • 80)/CO dynes/sec/cm-L Stroke volume (SV) was calculated as cardiac output divided by heart rate. Blood samples were drawn from the arterial and pulmonary artery catheters and analyzed on a Radiometer ~ ABL 2 electrode for Poe, Pco2, pH, and standard bicarbonate.
Anaesthesia was induced with a sleep dose of thiopentone, mean dose 170 mg (range 125-225 mg). Tracheal intubation was performed using intravenous succinylcholine 1 mg/kg. Enflurane was administered from a calibrated vaporizer (enflurotec, Cyprane) in a concentration of three per cent for eight minutes and thereafter two petcent for the remainder of the study. Pure oxygen was used as the carrying gas. Relaxation was achieved by the intravenous adminstration of pancuronium (0.1 mg/kg) and respiration was 113 controlled by a Bird mark 4 respirator using a gas flow of four litres/minute and a semiclosed circle system. The patients were ventilated with a tidal volume of' 10 ml/kg at a frequency of 14 per minute. Statistical analyses were performed using paired t-test. A p-value of less than 0.05 was considered statistically significant.
RESULTS
The results of enflurane-pancuronium anaesthesia are shown in Table I , Cardiac index declined from 2.8 +--0.2 litres/min to 2.5 -0.2 litres/min (p < 0.01). This was due mainly to a decline in stroke volume from 60 "," 5.6 to46 ---5.4 ml (p < 0.01). Heart rate increased in five patients, fiom 80 +--5.6 to 93 ---3.6 beats per minute. All other parameters were essentially unaffected. Blood gas measurements showed an expected rise in arterial oxygen tension from 80.5 -+ 4.3 to 419.7 -40,1 mm Hg whereas no change occurred in the carbon dioxide tension (Table ll) . DISCUSSION At,the time of measurements during enflurane-pancuronium anaesthesia the cardiovascular effects of the premedicat[on and the succinylcholine used for intubation must be considered minimal. If any lingering effect of the small amount of barbiturate used for induction should have influenced our results it should have been in the direction of a cardiovascular depression of direct as well as central sympathetic origin. 8 Diazepam was chosen for premeditation because of its potent sedative and minimal cardiovascular influence (Dalen, et al. 1969 ). 9 Scopolamine was chosen for its lack of chronotropic effect (Gravenstein and Thornby 1969)/0 which makes it preferable to atropine when tachycardia should be avoided, as in patients with cardiac valvular disease where digitalis is discontinued at least 24 hours prior to surgery. Pancuronium has been shown to increase arterial pressure and cardiac index during halothane anaesthesia due to an increased pulse rate, believed to be of vagolytic origin (Stoelting 1972)? ~ It is therefore not improbable that the cardiovascular actions of enflurane observed in this study were modified by the simultaneous use of pancuronium, On the other hand, our findings reflect the every-day clinical use ofenflurane in patients with cardiac valvular disease. A ten per cent depression was found in cardiac output. This was due to a decline in stroke volume, undoubtedly because of the myocardial depressant actions of enflurane, j.z Our findings in this respect closely resemble those of Marshall, et al, 1971.4 In unpremedicated healthy volunteers Levesque, et al. 5 found no change in cardiac output after enflurane at an end-tidal concentration of 2.3 per cent. Stroke volume was depressed but pulse rate also found enflurane without effect on systemic resistance when added in a concentration of two per cent to the gas flow of a heartlung apparatus. The haemodynamics of the pulmonary circulation were found unaffected by enflurane. Similar results were obtained by Morr-Strathmann and Lawin.~3 They found pulmonary arterial pressure to increase from 22 to 26 mm Hg during enflurane-pancuronium anaesthesia in man, a change that was probably induced by the change in intrathoracic pressure resulting from the change from spontaneous to controlled ventilation. It is puzzling that we found no increase in wedge pressure, central venous pressure or pulmonary artery pressure as a result of controlled ventilation. All recorded parameters as well as arterial pressure rose markedly during intubation, as has been observed in other studies (Serensen and Jacobsen~'*), but they returned to stable pre-anaesthetic levels at the time of measurement after 15 minutes of enflurane anaesthesia.
Two groups of investigators t2'~3 warn against the use of enflurane in patients with limited cardiac reserve because of marked cardiovascular depression. Morr-Strathmann and Lawin t3 found two per cent enflurane to depress cardiac output 20 per cent in physical status i patients. These patients who were paralyzed with pancmonium and mechanically ventilated with 50 per cent nitrous oxide-oxygen and enflurane were premedicated with atropine, which possibly could explain why the pulse did not increase during anaesthesia. Karliczek, et al. 12 found a 25 per cent depression in cardiac output when two per cent enflurane was added to the inspired air of cardiac patients already anaesthetized with "neurolept anaesthesia" and with the pericardium open. The multitude of factors in this study such as premedication, "basal anaesthesia", mechanical ventilation and surgical trauma make the evaluation of cardiovascular changes induced by enflurane itself difficult.
On the basis of our findings we conclude that enflurane-pancuronium anaesthesia in patients with valvular heart diseases is associated with only minimal cardiovascular depression and unchanged pulmonary vascular haemodynamics.
SUMMARY
The effects of enflurane-pancuronium anaesthesia on cardiovascular haemodynamics were studied before operation in six patients with valvular heart disease. A ten per cent decline in cardiac index and a 20 per cent decline in stroke volume were the only changes observed. Mean arterial, pulmonary arterial, central venous, and pulmonary capillary wedge pressures were unaffected, as were systemic vascular resistance and pulmonary vascular resistance.
The authors therefore conclude that enflurane-pancuronium anaesthesia causes only minimal cardiovascular depression in patients with valvular heart disease.
RI~SUMI~
Les effets cardiovasculaires d'une anesth6sie 5. l'enflurane-pancuronium ont El6 6tudids chez six op6r6s prdsentant une pathologie valvulaire. Une diminution de l0 pour cent de I'index cardiaque et de 20 pour cent du volume d'6jection ont 6td les seules modifications observ6es. La pression art6rielle moyenne, la pression de l'art/~re pulmonaire, la tension veineuse centrale et la pression capillaire bloqu6e 6talent inchang6es, de m6me que les r6sistances vasculaires pdriph6-riques et pulmonaires.
Les auteurs concluent qu'une anesthdsie /i I'enflurane-pancuronium ne cause qu'une d6-pression cardiovasculaire minime chez des patients prdsentant une atteinte valvulaire.
